MRI, Clinical Examination, and Mammography for Preoperative Assessment of Residual Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: ACRIN 6657 Trial.

John R Scheel,Eunhee Kim,Savannah C Partridge,Constance D Lehman,Mark A Rosen,Wanda K Bernreuter,Etta D Pisano,Helga S Marques,Elizabeth A Morris,Paul T Weatherall,Sandra M Polin,Gillian M Newstead,Laura J Esserman,Mitchell D Schnall,Nola M Hylton
DOI: https://doi.org/10.2214/AJR.17.18323
2019-10-03
American Journal of Roentgenology
Abstract:The objective of our study was to determine the accuracy of preoperative measurements for detecting pathologic complete response (CR) and assessing residual disease after neoadjuvant chemotherapy (NACT) in patients with locally advanced breast cancer.
radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?